The Journal of Allergy and Clinical Immunology
Volume 111, Issue 1 , Pages 45-50 , January 2003

Responses to bronchial challenge submitted for approval to use inhaled β2-agonists before an event at the 2002 winter olympics

Received 25 July 2002 ,Revised 8 September 2002 ,Accepted 16 September 2002.

  • Image Result

    Individual values for the decrease in FEV1 after exercise (n = 40) or EVH (n = 17) in 57 athletes expressed as a percentage of the prechallenge value (percentage decrease in FEV1). Thirty-six athletes

    Individual values for the decrease in FEV1 after exercise (n = 40) or EVH (n = 17) in 57 athletes expressed as a percentage of the prechallenge value (percentage decrease in FEV1). Thirty-six athletes had a decrease in FEV1 of 10% or greater, the value considered as the cutoff point for a positive response. Nineteen of these 36 were taking inhaled steroids. Of the 21 athletes who had negative results, 12 were taking inhaled steroids.

  • Image Result
    Individual values for the dose of methacholine (n = 40) or histamine (n = 5) required to provoke a 20% decrease in FEV1 (PD20 FEV1) in those athletes with a positive response. Broken lines represent t

    Individual values for the dose of methacholine (n = 40) or histamine (n = 5) required to provoke a 20% decrease in FEV1 (PD20 FEV1) in those athletes with a positive response. Broken lines represent the acceptable values for PD20 for those not taking (lower line) and those taking (upper line) inhaled steroids. The equivalence values for the provoking concentration of agent are also given. Thirty-five subjects submitted PD20 values, and 10 submitted PC20 values.

 Supported by the Medical Commission of the International Olympic Committee.

☆☆ Reprint requests: Sandra Anderson, PhD, DSc, Department of Respiratory Medicine, E11S, Royal Prince Alfred Hospital, Camperdown NSW 2050, Australia.

PII: S0091-6749(02)91524-1

doi: 10.1067/mai.2003.1

The Journal of Allergy and Clinical Immunology
Volume 111, Issue 1 , Pages 45-50 , January 2003